CHARLES H HOOD FOUNDATION: Form 990PF, tax year 2022

View the entire original 990 at ProPublica ↗

Organization
CHARLES H HOOD FOUNDATION (EIN 04-3507847)
Tax period
2022-01-01 to 2022-12-31
Filed
2023-11-01
IRS object ID
202333059349100518
Schema version
2022v5.0
Source
Download XML · Original 990 at ProPublica

Every field in the e-filed return. Faint text is the IRS element name, for citing.

Return header ReturnHeader

FieldValueIRS element (for citing)
Return2023-11-01T14:47:55-05:00ReturnTs
Tax Period End2022-12-31TaxPeriodEndDt

Preparer Firm PreparerFirmGrp

FieldValueIRS element (for citing)
Preparer Firm EIN042571780PreparerFirmEIN

Preparer Firm Name PreparerFirmName

FieldValueIRS element (for citing)
Business Name Line1AAFCPAS INCBusinessNameLine1Txt

Preparer US Address PreparerUSAddress

FieldValueIRS element (for citing)
Address Line150 WASHINGTON STREETAddressLine1Txt
CityWESTBOROUGHCityNm
State AbbreviationMAStateAbbreviationCd
ZIP01581ZIPCd
FieldValueIRS element (for citing)
Return Type990PFReturnTypeCd
Tax Period Begin2022-01-01TaxPeriodBeginDt

Filer Filer

FieldValueIRS element (for citing)
EIN043507847EIN

Business Name BusinessName

FieldValueIRS element (for citing)
Business Name Line1CHARLES H HOOD FOUNDATIONBusinessNameLine1Txt
FieldValueIRS element (for citing)
Business Name ControlCHARBusinessNameControlTxt
Phone6172792230PhoneNum

US Address USAddress

FieldValueIRS element (for citing)
Address Line12 BOYLSTON STREET 4TH FLOORAddressLine1Txt
CityBOSTONCityNm
State AbbreviationMAStateAbbreviationCd
ZIP02116ZIPCd

Business Officer BusinessOfficerGrp

FieldValueIRS element (for citing)
PersonNEIL SMILEYPersonNm
Person TitlePRESIDENT AND TREASURERPersonTitleTxt
Phone6172792230PhoneNum
Signature2023-10-24SignatureDt
Discuss With Paid PreparerYes (1)DiscussWithPaidPreparerInd

Signing Officer SigningOfficerGrp

Person Full Name PersonFullName

FieldValueIRS element (for citing)
Person FirstNEILPersonFirstNm
Person LastSMILEYPersonLastNm
FieldValueIRS element (for citing)
SSNXXX-XX-XXXXSSN
FieldValueIRS element (for citing)
IRS Responsible Prty Info CurrYes (1)IRSResponsiblePrtyInfoCurrInd

Preparer Person PreparerPersonGrp

FieldValueIRS element (for citing)
Preparer PersonJOYCE RIPIANZI CPAPreparerPersonNm
PTINP00548581PTIN
Phone5083669100PhoneNum
Preparation2023-10-24PreparationDt

Additional Filer Information AdditionalFilerInformation

Trusted Customer TrustedCustomerGrp

FieldValueIRS element (for citing)
Trusted Customer2TrustedCustomerCd
Authentication Assurance LevelAAL1AuthenticationAssuranceLevelCd
Identity Assurance LevelIAL1IdentityAssuranceLevelCd
FieldValueIRS element (for citing)
Tax2022TaxYr
Build TS2023-04-26 12:10:37ZBuildTS

Form 990-PF IRS990PF

FieldValueIRS element (for citing)
Organization501c3 Exempt PFYes (X)Organization501c3ExemptPFInd
FMV Assets EOY$66,678,123FMVAssetsEOYAmt
Method Of Accounting CashYes (X)MethodOfAccountingCashInd

Analysis Of Revenue And Expenses AnalysisOfRevenueAndExpenses

FieldValueIRS element (for citing)
Contri Rcvd Rev And Expnss$1,029,761ContriRcvdRevAndExpnssAmt
Dividends Rev And Expnss$1,335,080DividendsRevAndExpnssAmt
Dividends Net Invst Incm$1,335,080DividendsNetInvstIncmAmt
Net Gain Sale Ast Rev And Expnss$612,940NetGainSaleAstRevAndExpnssAmt
Gross Sales Price$3,183,933GrossSalesPriceAmt
Cap Gain Net Incm Net Invst Incm$612,940CapGainNetIncmNetInvstIncmAmt
Incm Modifications Adj Net Incm$31,917IncmModificationsAdjNetIncmAmt
Other Income Rev And Expnss$37,260OtherIncomeRevAndExpnssAmt
Other Income Net Invst Incm$0OtherIncomeNetInvstIncmAmt
Total Rev And Expnss$3,015,041TotalRevAndExpnssAmt
Total Net Invst Incm$1,948,020TotalNetInvstIncmAmt
Total Adj Net Incm$31,917TotalAdjNetIncmAmt
Comp Ofcr Dir Trst Rev And Expnss$0CompOfcrDirTrstRevAndExpnssAmt
Comp Ofcr Dir Trst Net Invst Incm$0CompOfcrDirTrstNetInvstIncmAmt
Comp Ofcr Dir Trst Dsbrs Chrtbl$0CompOfcrDirTrstDsbrsChrtblAmt
Legal Fees Rev And Expnss$30,210LegalFeesRevAndExpnssAmt
Legal Fees Net Invst Incm$0LegalFeesNetInvstIncmAmt
Legal Fees Dsbrs Chrtbl$30,210LegalFeesDsbrsChrtblAmt
Accounting Fees Rev And Expnss$26,003AccountingFeesRevAndExpnssAmt
Accounting Fees Net Invst Incm$0AccountingFeesNetInvstIncmAmt
Accounting Fees Chrtbl Prps$26,003AccountingFeesChrtblPrpsAmt
Other Prof Fees Rev And Expnss$103,585OtherProfFeesRevAndExpnssAmt
Other Prof Fees Net Invst Incm$89,292OtherProfFeesNetInvstIncmAmt
Other Prof Fees Dsbrs Chrtbl$14,293OtherProfFeesDsbrsChrtblAmt
Taxes Rev And Expnss$83,679TaxesRevAndExpnssAmt
Taxes Net Invst Incm$25,400TaxesNetInvstIncmAmt
Taxes Dsbrs Chrtbl$500TaxesDsbrsChrtblAmt
Trav Conf Meeting Rev And Expnss$23,125TravConfMeetingRevAndExpnssAmt
Trav Conf Meeting Net Invst Incm$0TravConfMeetingNetInvstIncmAmt
Trav Conf Meeting Dsbrs Chrtbl$23,125TravConfMeetingDsbrsChrtblAmt
Other Expenses Rev And Expnss$398,201OtherExpensesRevAndExpnssAmt
Other Expenses Net Invst Incm$0OtherExpensesNetInvstIncmAmt
Other Expenses Dsbrs Chrtbl$398,201OtherExpensesDsbrsChrtblAmt
Tot Opr Expenses Rev And Expnss$664,803TotOprExpensesRevAndExpnssAmt
Tot Opr Expenses Net Invst Incm$114,692TotOprExpensesNetInvstIncmAmt
Tot Opr Expenses Dsbrs Chrtbl$492,332TotOprExpensesDsbrsChrtblAmt
Contri Paid Rev And Expnss$2,662,000ContriPaidRevAndExpnssAmt
Contri Paid Dsbrs Chrtbl$2,662,000ContriPaidDsbrsChrtblAmt
Total Expenses Rev And Expnss$3,326,803TotalExpensesRevAndExpnssAmt
Total Expenses Net Invst Incm$114,692TotalExpensesNetInvstIncmAmt
Total Expenses Dsbrs Chrtbl$3,154,332TotalExpensesDsbrsChrtblAmt
Excess Revenue Over Expenses-$311,762ExcessRevenueOverExpensesAmt
Net Investment Income$1,833,328NetInvestmentIncomeAmt
Adjusted Net Income$31,917AdjustedNetIncomeAmt

Form990 PF Balance Sheets Form990PFBalanceSheetsGrp

FieldValueIRS element (for citing)
Sav And Temp Cash Invst BOY$679,672SavAndTempCashInvstBOYAmt
Sav And Temp Cash Invst EOY$383,193SavAndTempCashInvstEOYAmt
Sav And Temp Cash Invst EOYFMV$383,193SavAndTempCashInvstEOYFMVAmt
Corporate Stock BOY$45,446,070CorporateStockBOYAmt
Corporate Stock EOY$34,837,751CorporateStockEOYAmt
Corporate Stock EOYFMV$34,837,751CorporateStockEOYFMVAmt
Corporate Bonds BOY$17,200,112CorporateBondsBOYAmt
Corporate Bonds EOY$13,292,160CorporateBondsEOYAmt
Corporate Bonds EOYFMV$13,292,160CorporateBondsEOYFMVAmt
Other Investments BOY$13,066,723OtherInvestmentsBOYAmt
Other Investments EOY$14,795,058OtherInvestmentsEOYAmt
Other Investments EOYFMV$14,795,058OtherInvestmentsEOYFMVAmt
Other Assets BOY$2,569,964OtherAssetsBOYAmt
Other Assets EOY$3,369,961OtherAssetsEOYAmt
Other Assets EOYFMV$3,369,961OtherAssetsEOYFMVAmt
Total Assets BOY$78,962,541TotalAssetsBOYAmt
Total Assets EOY$66,678,123TotalAssetsEOYAmt
Total Assets EOYFMV$66,678,123TotalAssetsEOYFMVAmt
Total Liabilities BOY$0TotalLiabilitiesBOYAmt
Total Liabilities EOY$0TotalLiabilitiesEOYAmt
Org Does Not Follow FASB117Yes (X)OrgDoesNotFollowFASB117Ind
Capital Stock BOY$59,300,755CapitalStockBOYAmt
Capital Stock EOY$59,300,755CapitalStockEOYAmt
Additional Paid In Capital BOY$0AdditionalPaidInCapitalBOYAmt
Additional Paid In Capital EOY$0AdditionalPaidInCapitalEOYAmt
Retained Earning BOY$19,661,786RetainedEarningBOYAmt
Retained Earning EOY$7,377,368RetainedEarningEOYAmt
Tot Net Ast Or Fund Balances BOY$78,962,541TotNetAstOrFundBalancesBOYAmt
Tot Net Ast Or Fund Balances EOY$66,678,123TotNetAstOrFundBalancesEOYAmt
Total Liabilities Net Ast BOY$78,962,541TotalLiabilitiesNetAstBOYAmt
Total Liabilities Net Ast EOY$66,678,123TotalLiabilitiesNetAstEOYAmt

Chg In Net Assets Fund Balances ChgInNetAssetsFundBalancesGrp

FieldValueIRS element (for citing)
Tot Net Ast Or Fund Balances BOY$78,962,541TotNetAstOrFundBalancesBOYAmt
Excess Revenue Over Expenses-$311,762ExcessRevenueOverExpensesAmt
Other Increases$0OtherIncreasesAmt
Subtotal$78,650,779SubtotalAmt
Other Decreases$11,972,656OtherDecreasesAmt
Tot Net Ast Or Fund Balances EOY$66,678,123TotNetAstOrFundBalancesEOYAmt

Cap Gains Loss Tx Invst Incm Detail CapGainsLossTxInvstIncmDetail

Cap Gains Loss Tx Invst Incm CapGainsLossTxInvstIncmGrp (2 entries)

PropertyPropertyDescGross Sales PriceGrossSalesPriceAmtCost Or Other BasisCostOrOtherBasisAmtGain Or LossGainOrLossAmtGains Minus Excess Or LossesGainsMinusExcessOrLossesAmtHow AcquiredHowAcquiredCd
PUBLICLY TRADED SECURITIES$2,816,232$2,570,993$245,239$245,239
CAPITAL GAINS DIVIDENDS$367,701$367,701$367,701P
FieldValueIRS element (for citing)
Capital Gain Net Income$612,940CapitalGainNetIncomeAmt

Excise Tax Based On Invst Incm ExciseTaxBasedOnInvstIncmGrp

FieldValueIRS element (for citing)
Investment Income Excise Tax$25,483InvestmentIncomeExciseTaxAmt
Tax Under Section511$0TaxUnderSection511Amt
Subtotal$25,483SubtotalAmt
Subtitle A Tax$0SubtitleATaxAmt
Tax Based On Investment Income$25,483TaxBasedOnInvestmentIncomeAmt
Estimated Plus Ovpmt Incm Tx$47,510EstimatedPlusOvpmtIncmTxAmt
Exempt Frgn Org Tax Wthld At Srce$0ExemptFrgnOrgTaxWthldAtSrceAmt
Extsn Request Income Tax Paid$0ExtsnRequestIncomeTaxPaidAmt
Backup Withholding Withheld$0BackupWithholdingWithheldAmt
Total Payments And Credits$47,510TotalPaymentsAndCreditsAmt
Es Penalty$0EsPenaltyAmt
Overpayment$22,027OverpaymentAmt
Applied To ES Tax$22,027AppliedToESTaxAmt
Refund$0RefundAmt

Statements Regarding Acty StatementsRegardingActyGrp

FieldValueIRS element (for citing)
Legislative Political Acty0LegislativePoliticalActyInd
More Than100 Spent0MoreThan100SpentInd
Form1120 POL Filed0Form1120POLFiledInd
Section4955 Organization Tax$0Section4955OrganizationTaxAmt
Section4955 Managers Tax$0Section4955ManagersTaxAmt
Tax Reimbursed$0TaxReimbursedAmt
Activities Not Previously Rpt0ActivitiesNotPreviouslyRptInd
Changes To Articles Or Bylaws0ChangesToArticlesOrBylawsInd
Unrelated Bus Incm Over LimitYes (1)UnrelatedBusIncmOverLimitInd
Form990 T FiledYes (1)Form990TFiledInd
Organization Dissolved Etc0OrganizationDissolvedEtcInd
Section508e Rqr SatisfiedYes (1)Section508eRqrSatisfiedInd
At Least5000 In AssetsYes (1)AtLeast5000InAssetsInd
Org Report Or Register StateMAOrgReportOrRegisterStateCd
Form990 PF Filed With Atty GenYes (1)Form990PFFiledWithAttyGenInd
Private Operating Foundation0PrivateOperatingFoundationInd
New Substantial Contributors0NewSubstantialContributorsInd
Own Controlled EntityYes (1)OwnControlledEntityInd
Donor Advised Fund0DonorAdvisedFundInd
Comply With Public Insp RqrYes (1)ComplyWithPublicInspRqrInd
Website AddressHTTPS://HRIA.ORG/TMF/HOOD/WebsiteAddressTxt
Individual With BooksAAFCPAS INCIndividualWithBooksNm
Phone5083669100PhoneNum

Location Of Books US Address LocationOfBooksUSAddress

FieldValueIRS element (for citing)
Address Line150 WASHINGTON STREETAddressLine1Txt
CityWESTBOROUGHCityNm
State AbbreviationMAStateAbbreviationCd
ZIP01581ZIPCd
FieldValueIRS element (for citing)
Foreign Accounts Question0ForeignAccountsQuestionInd

Statements Regarding Acty4720 StatementsRegardingActy4720Grp

FieldValueIRS element (for citing)
Sale Or Exch Disqualified Prsn0SaleOrExchDisqualifiedPrsnInd
Brrw Or Lend Disqualified Prsn0BrrwOrLendDisqualifiedPrsnInd
Furn Goods Disqualified Prsn0FurnGoodsDisqualifiedPrsnInd
Pay Comp Disqualified PrsnYes (1)PayCompDisqualifiedPrsnInd
Transfer Ast Disqualified Prsn0TransferAstDisqualifiedPrsnInd
Payment To Government Official0PaymentToGovernmentOfficialInd
Acts Fail To Qlfy As Exceptions0ActsFailToQlfyAsExceptionsInd
Uncorrected Prior Acts0UncorrectedPriorActsInd
Undistributed Income PY0UndistributedIncomePYInd
Business HoldingsYes (1)BusinessHoldingsInd
Excess Business Holdings0ExcessBusinessHoldingsInd
Jeopardy Investments0JeopardyInvestmentsInd
Uncorrected PY Jeopardy Invst0UncorrectedPYJeopardyInvstInd
Influence Legislation0InfluenceLegislationInd
Influence Election0InfluenceElectionInd
Grants To Individuals0GrantsToIndividualsInd
Grants To OrganizationsYes (1)GrantsToOrganizationsInd
Noncharitable Purpose0NoncharitablePurposeInd
Transactions Fail To Qlfy As Exc0TransactionsFailToQlfyAsExcInd
Maintained Expenditure RspnsYes (1)MaintainedExpenditureRspnsInd
Rcv Fnds To Pay Prsnl Bnft Cntrct0RcvFndsToPayPrsnlBnftCntrctInd
Pay Premiums Prsnl Bnft Cntrct0PayPremiumsPrsnlBnftCntrctInd
Prohibited Tax Shelter Trans0ProhibitedTaxShelterTransInd
Subj To Tax Rmnrtn Ex Prcht Pymt0SubjToTaxRmnrtnExPrchtPymtInd

Officer Dir Trst Key Empl Info OfficerDirTrstKeyEmplInfoGrp

Officer Dir Trst Key Empl OfficerDirTrstKeyEmplGrp (7 entries)

Address Line1USAddress/AddressLine1TxtCityUSAddress/CityNmState AbbreviationUSAddress/StateAbbreviationCdZIPUSAddress/ZIPCdTitleTitleTxtAverage Hrs Per Wk Devoted To PosAverageHrsPerWkDevotedToPosRtCompensationCompensationAmtEmployee Benefit ProgramEmployeeBenefitProgramAmtExpense Account Other AllwncExpenseAccountOtherAllwncAmt
NEIL SMILEY
2 BOYLSTON STREET 4TH FLOORBOSTONMA02116PRESIDENT AND TREASURER1.00$0$0$0
JOHN O PARKER JR
2 BOYLSTON STREET 4TH FLOORBOSTONMA02116VICE PRESIDENT AND CLERK1.00$0$0$0
ROBERT C BOUTWELL
2 BOYLSTON STREET 4TH FLOORBOSTONMA02116TRUSTEE1.00$0$0$0
BARBARA BULA
2 BOYLSTON STREET 4TH FLOORBOSTONMA02116TRUSTEE1.00$0$0$0
BRENDON BULA
2 BOYLSTON STREET 4TH FLOORBOSTONMA02116TRUSTEE1.00$0$0$0
ELIZABETH HOOD
2 BOYLSTON STREET 4TH FLOORBOSTONMA02116TRUSTEE1.00$0$0$0
CLAY SMILEY
2 BOYLSTON STREET 4TH FLOORBOSTONMA02116TRUSTEE1.00$0$0$0
FieldValueIRS element (for citing)
Comp Of Hghst Pd Empl Or NONENONECompOfHghstPdEmplOrNONETxt
Other Employee Paid Over50k0OtherEmployeePaidOver50kCnt

Compensation Of Hghst Pd Cntrct CompensationOfHghstPdCntrctGrp (2 entries)

Address Line1USAddress/AddressLine1TxtCityUSAddress/CityNmState AbbreviationUSAddress/StateAbbreviationCdZIPUSAddress/ZIPCdService TypeServiceTypeTxtCompensationCompensationAmt
HEALTH RESOURCES IN ACTION
2 BOYLSTON STREET 4TH FLOORBOSTONMA02116ADMINISTRATIVE FEES$199,378
PRIME BUCHHOLZ
273 CORPORATE DRIVE SUITE 250PORTSMOUTHNH03801INVESTMENT ADVISORY SERVICES$75,000
FieldValueIRS element (for citing)
Contractor Paid Over50k0ContractorPaidOver50kCnt

Sum Of Program Related Invst SumOfProgramRelatedInvstGrp

FieldValueIRS element (for citing)
Description1INKSPACE IMAGING, INC. - PLEASANTON, CACONVERTIBLE PROMISSORY NOTEDescription1Txt
Expenses1$250,000Expenses1Amt
Description2DECK THERAPEUTICS, INC. - HUDSON, NY SAFE - SIMPLE AGREEMENT FOR FUTURE EQUITYDescription2Txt
Expenses2$200,000Expenses2Amt
All Other Program Rltd Invst Tot$349,997AllOtherProgramRltdInvstTotAmt
Total$799,997TotalAmt

Minimum Investment Return MinimumInvestmentReturnGrp

FieldValueIRS element (for citing)
Average Monthly FMV Of Sec$55,574,961AverageMonthlyFMVOfSecAmt
Average Monthly Cash Balances$377,542AverageMonthlyCashBalancesAmt
FMV All Other Noncharitable Ast$12,208,432FMVAllOtherNoncharitableAstAmt
Total FMV Of Unused Assets$68,160,935TotalFMVOfUnusedAssetsAmt
Reduction Claimed$0ReductionClaimedAmt
Acquisition Indebtedness$0AcquisitionIndebtednessAmt
Adjusted Total FMV Of Unused Ast$68,160,935AdjustedTotalFMVOfUnusedAstAmt
Cash Deemed Charitable$1,022,414CashDeemedCharitableAmt
Net Vl Noncharitable Assets$67,138,521NetVlNoncharitableAssetsAmt
Minimum Investment Return$3,356,926MinimumInvestmentReturnAmt

Distributable Amount DistributableAmountGrp

FieldValueIRS element (for citing)
Minimum Investment Return$3,356,926MinimumInvestmentReturnAmt
Tax Based On Investment Income$25,483TaxBasedOnInvestmentIncomeAmt
Total Tax$25,483TotalTaxAmt
Distributable Before Adj$3,331,443DistributableBeforeAdjAmt
Recoveries Qualfied Distri$31,917RecoveriesQualfiedDistriAmt
Distributable Before Ded$3,363,360DistributableBeforeDedAmt
Deduction From Distributable$0DeductionFromDistributableAmt
Distributable As Adjusted$3,363,360DistributableAsAdjustedAmt

PF Qualifying Distributions PFQualifyingDistributionsGrp

FieldValueIRS element (for citing)
Expenses And Contributions$3,154,332ExpensesAndContributionsAmt
Program Related Invst Total$799,997ProgramRelatedInvstTotalAmt
Qualifying Distributions$3,954,329QualifyingDistributionsAmt

Undistributed Income UndistributedIncomeGrp

FieldValueIRS element (for citing)
Distributable As Adjusted$3,363,360DistributableAsAdjustedAmt
Undistributed Income PY$3,892,877UndistributedIncomePYAmt
Total For Prior Years$0TotalForPriorYearsAmt
Total Excess Distribution Cyov$0TotalExcessDistributionCyovAmt
Qualifying Distributions$3,954,329QualifyingDistributionsAmt
Applied To Year1$3,892,877AppliedToYear1Amt
Applied To Prior Years$0AppliedToPriorYearsAmt
Treated As Distri From Corpus$0TreatedAsDistriFromCorpusAmt
Applied To Current Year$61,452AppliedToCurrentYearAmt
Remaining Distri From Corpus$0RemainingDistriFromCorpusAmt
Excess Distri Cyov App CY Corpus$0ExcessDistriCyovAppCYCorpusAmt
Excess Distribution Cyov App CY$0ExcessDistributionCyovAppCYAmt
Total Corpus$0TotalCorpusAmt
Prior Year Undistributed Incm$0PriorYearUndistributedIncmAmt
Prior Year Deficiency Or Tax$0PriorYearDeficiencyOrTaxAmt
Taxable1$0Taxable1Amt
Taxable2$0Taxable2Amt
Undistributed Income CY$3,301,908UndistributedIncomeCYAmt
Corpus Distri170b1 E Or4942g3$0CorpusDistri170b1EOr4942g3Amt
Excess Distri Cyov From Yr5$0ExcessDistriCyovFromYr5Amt
Excess Distri Cyov To Next Yr$0ExcessDistriCyovToNextYrAmt

Supplementary Information SupplementaryInformationGrp

Application Submission Info ApplicationSubmissionInfoGrp

FieldValueIRS element (for citing)
Recipient PersonCHARLENE MANCUSI DIRECTOR HRIARecipientPersonNm

Recipient US Address RecipientUSAddress

FieldValueIRS element (for citing)
Address Line12 BOYLSTON STREET 4TH FLOORAddressLine1Txt
CityBOSTONCityNm
State AbbreviationMAStateAbbreviationCd
ZIP02116ZIPCd
FieldValueIRS element (for citing)
Recipient Phone6176959439RecipientPhoneNum
Recipient Email AddressCMANCUSI@HRIA.ORGRecipientEmailAddressTxt
Form And Info And MaterialsAPPLICATION FORMS AVAILABLE AT WWW.TMFGRANTS.ORG/HOODFormAndInfoAndMaterialsTxt
Submission DeadlinesANNUALLY MARCH AND OCTOBERSubmissionDeadlinesTxt
Restrictions On AwardsRESTRICTED TO PEDIATRIC RESEARCHRestrictionsOnAwardsTxt

Grant Or Contribution Pd Dur Yr GrantOrContributionPdDurYrGrp (22 entries)

Address Line1RecipientUSAddress/AddressLine1TxtCityRecipientUSAddress/CityNmState AbbreviationRecipientUSAddress/StateAbbreviationCdZIPRecipientUSAddress/ZIPCdRecipient Foundation StatusRecipientFoundationStatusTxtGrant Or Contribution PurposeGrantOrContributionPurposeTxtAmtAmtAddress Line2RecipientUSAddress/AddressLine2Txt
BOSTON MEDICAL CENTER
660 HARRISON AVENUE 2ND FLOORBOSTONMA02118PCMAJOR GRANT - BEYOND WATCHING AND WAITING: A NOVEL COLLABORATION TO PREVENT AND REDUCE THE BURDEN OF MENTAL ILLNESS IN HIGH-RISK, UNDERSERVED YOUTH WITH EPILEPSY$225,000
TRUSTEES OF DARTMOUTH COLLEGE
OFFICE OF SPONSORED PROJECTS 11HANOVERNH037551421PCMAJOR GRANT - DECREASING HARMS AND IMPROVING CHILD HEALTH: AN INTERVENTION TO REDUCE INAPPROPRIATE USE OF ANTIPSYCHOTICS AND POLYPHARMACY$379,750ROPE FERRY ROAD
BOSTON CHILDREN'S HOSPITAL
PO BOX 414413BOSTONMA022414413PCCHILD HEALTH RESEARCH AWARD - DYSREGULATED T AND B CELL INTERACTIONS IN EARLY-ONSET OLIGOARTICULAR JUVENILE IDIOPATHIC ARTHRITIS$82,500
DANA-FARBER CANCER INSTITUTE
450 BROOKLINE AVE BP437BOSTONMA022155450PCCHILD HEALTH RESEARCH AWARD - MACHINE LEARNING-BASED RISK PREDICTION FOR CHILDREN WITH MEDULLOBLASTOMA$82,500
YALE SCHOOL OF MEDICINE
PO BOX 1873NEW HAVENCT065081873PCCHILD HEALTH RESEARCH AWARD - DYSREGULATED RNA MODIFICATIONS IN THE CONTEXT OF HUMAN DEVELOPMENT$82,500
MASSACHUSETTS GENERAL HOSPITAL
C/O BANK OF AMERICA NA PO BOXBOSTONMA022414876PCCHILD HEALTH RESEARCH AWARD - ILLUMINATING THE FUNCTION OF POLYCYSTINS AS CILIARY MECHANOTRANSDUCERS IN LEFT-RIGHT AXIS DEVELOPMENT$82,500414876
HARVARD UNIVERSITY
PO BOX 415649BOSTONMA022415649PCCHILD HEALTH RESEARCH AWARD - MATURATION OF THE UTERUS DURING PUBERTY$82,500
YALE SCHOOL OF MEDICINE
PO BOX 1873NEW HAVENCT065081873PCCHILD HEALTH RESEARCH AWARD - IDENTIFYING THE CELL OF ORIGIN IN INTESTINAL CYSTIC FIBROSIS DISEASE$82,500
UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL
55 LAKE AVENUE NORTHWORCESTERMA01655PCCHILD HEALTH RESEARCH AWARD - UNDERSTANDING NEONATAL INDUCTION OF PROALLERGIC T FOLLICULAR HELPER CELLS$82,500
UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL
C/O BANK OF AMERICA 222 BROADWAY STNEW YORKNY10038PCCHILD HEALTH RESEARCH AWARD - THE ROLE OF MARCO IN PEDIATRIC CANCER$82,500
MASSACHUSETTS INSTITUTE OF TECHNOLOGY
C/O BANK OF AMERICA 100 FEDERALBOSTONMA02110PCCHILD HEALTH RESEARCH AWARD - THE ROLE OF AIRWAY NEURONS IN CHILDHOOD ASTHMA$82,500STREET
BOSTON CHILDREN'S HOSPITAL
C/O BANK OF AMERICA 100 FEDERALBOSTONMA02110PCCHILD HEALTH RESEARCH AWARD - DEVELOPING A BROADLY APPLICABLE THERAPEUTIC STRATEGY TO REVERSE SYMPTOMS OF NEURODEVELOPMENTAL DISORDERS$82,500STREET
YALE SCHOOL OF MEDICINE
PO BOX 208239NEW HAVENCT065208239PCCHILD HEALTH RESEARCH AWARD - NEURAL MARKERS OF CHRONIC, PERSISTENT PEDIATRIC IRRITABILITY$82,500
BRIGHAM AND WOMEN'S HOSPITAL
C/O BANK OF AMERICA 100 FEDERALBOSTONMA02110PCCHILD HEALTH RESEARCH AWARD - SPATIAL MAPPING OF MALIGNANT SUBPOPULATIONS ENABLING NEURON-GLIOMA CIRCUIT INTERACTIONS IN DIPG$82,500STREET
BOSTON CHILDREN'S HOSPITAL
C/O BANK OF AMERICA 100 FEDERALBOSTONMA02110PCCHILD HEALTH RESEARCH AWARD - DISSECTING IMMUNE-STROMAL INTERACTIONS TO DISCOVER NOVEL STRATEGY TO MODULATE INFLAMMATION$82,500STREET
BOSTON CHILDREN'S HOSPITAL
C/O BANK OF AMERICA 100 FEDERALBOSTONMA02110PCCHILD HEALTH RESEARCH AWARD - THE ROLE AND MECHANISM OF MAKORIN RING FINGER PROTEIN 3 IN CHILDREN WITH DELAYED PUBERTY$160,000STREET
BOSTON CHILDREN'S HOSPITAL
C/O BANK OF AMERICA 1295 BOYLSTONBOSTONMA022155724PCCHILD HEALTH RESEARCH AWARD - MACHINE-LEARNING PREDICTION MODEL FOR PERSONALIZED URINARY TRACT INFECTION CARE IN CHILDREN$160,000STREET 4TH FL
BROWN UNIVERSITY
CASHIER OFFICE BOX 1997 69 BROWNPROVIDENCERI02912PCCHILD HEALTH RESEARCH AWARD - DEVELOPMENT OF A HIGH EFFICACY NON-CAPSID NOROVIRUS VACCINE$160,000STREET 2ND FLOOR
HARVARD MEDICAL SCHOOL
C/O BANK OF AMERICA 100 FEDERALBOSTONMA02110PCCHILD HEALTH RESEARCH AWARD - DECIPHERING MECHANISMS LINKING CHILDHOOD VIRAL INFECTION AND ASTHMA DEVELOPMENT$160,000STREET
WORCESTER POLYTECHNIC INSTITUTE
C/O TD BANK 370 MAIN STWORCESTERMA01608PCCHILD HEALTH RESEARCH AWARD - ROLE OF HETEROTRIMERIC G PROTEINS IN CILIA ASSEMBLY AND PATHOGENESIS OF NEURODEVELOPMENTAL DISORDERS$160,000
YALE UNIVERSITY
C/O BANK OF AMERICA MERRILL LYNCHNEW YORKNY10001PCCHILD HEALTH RESEARCH AWARD - DIAGNOSIS OF PEDIATRIC MALIGNANCIES USING DEVELOPMENTAL MAPPING AND MACHINE LEARNING$160,000100 WEST 33RD STREET
RHODE ISLAND HOSPITAL
LIFESPAN OFFICE OF RESEARCH GRANTSPROVIDENCERI029034771PCSUPPLEMENTAL FUNDING ASSISTANCE DUE TO COVID IMPACTS, FOR PRIOR CHILD HEALTH RESEARCH AWARD - EVALUATION OF POST-TUBERCULOSIS LUNG FUNCTION IN ADOLESCENTS$24,750CONTRACTS 167 POINT STREET BOX 42 C
FieldValueIRS element (for citing)
Total Grant Or Contri Pd Dur Yr$2,662,000TotalGrantOrContriPdDurYrAmt

Grant Or Contri Apprv For Fut GrantOrContriApprvForFutGrp (14 entries)

Address Line1RecipientUSAddress/AddressLine1TxtCityRecipientUSAddress/CityNmState AbbreviationRecipientUSAddress/StateAbbreviationCdZIPRecipientUSAddress/ZIPCdRecipient Foundation StatusRecipientFoundationStatusTxtGrant Or Contribution PurposeGrantOrContributionPurposeTxtAmtAmtAddress Line2RecipientUSAddress/AddressLine2Txt
HARVARD MEDICAL SCHOOL
25 SHATTUCK STBOSTONMA02115PCCHARLES AWARD [CHARLES H. HOOD ALUMNI RECOGNITION FOR LEADERSHIP, EXCELLENCE AND SERVICE] - PRESENTED TO DR. ISAAC KOHANE, MD, PHD AT FOUNDATION'S 85TH ANNIVERSARY EVENT$100,000
TRUSTEES OF DARTMOUTH COLLEGE
OFFICE OF SPONSORED PROJECTS 11HANOVERNH037551421PCMAJOR GRANT - DECREASING HARMS AND IMPROVING CHILD HEALTH: AN INTERVENTION TO REDUCE INAPPROPRIATE USE OF ANTIPSYCHOTICS AND POLYPHARMACY$70,250ROPE FERRY ROAD
UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL
C/O BANK OF AMERICA 222 BROADWAY STNEW YORKNY10038PCCHILD HEALTH RESEARCH AWARD - THE ROLE OF MARCO IN PEDIATRIC CANCER$82,500
MASSACHUSETTS INSTITUTE OF TECHNOLOGY
C/O BANK OF AMERICA 100 FEDERALBOSTONMA02110PCCHILD HEALTH RESEARCH AWARD - THE ROLE OF AIRWAY NEURONS IN CHILDHOOD ASTHMA$82,500STREET
BOSTON CHILDREN'S HOSPITAL
C/O BANK OF AMERICA 100 FEDERALBOSTONMA02110PCCHILD HEALTH RESEARCH AWARD - DEVELOPING A BROADLY APPLICABLE THERAPEUTIC STRATEGY TO REVERSE SYMPTOMS OF NEURODEVELOPMENTAL DISORDERS$82,500STREET
YALE SCHOOL OF MEDICINE
PO BOX 208239NEW HAVENCT065208239PCCHILD HEALTH RESEARCH AWARD - NEURAL MARKERS OF CHRONIC, PERSISTENT PEDIATRIC IRRITABILITY$82,500
BRIGHAM AND WOMEN'S HOSPITAL
C/O BANK OF AMERICA 100 FEDERALBOSTONMA02110PCCHILD HEALTH RESEARCH AWARD - SPATIAL MAPPING OF MALIGNANT SUBPOPULATIONS ENABLING NEURON-GLIOMA CIRCUIT INTERACTIONS IN DIPG$82,500STREET
BOSTON CHILDREN'S HOSPITAL
C/O BANK OF AMERICA 100 FEDERALBOSTONMA02110PCCHILD HEALTH RESEARCH AWARD - DISSECTING IMMUNE-STROMAL INTERACTIONS TO DISCOVER NOVEL STRATEGY TO MODULATE INFLAMMATION$82,500STREET
BOSTON CHILDREN'S HOSPITAL
C/O BANK OF AMERICA 100 FEDERALBOSTONMA02110PCCHILD HEALTH RESEARCH AWARD - THE ROLE AND MECHANISM OF MAKORIN RING FINGER PROTEIN 3 IN CHILDREN WITH DELAYED PUBERTY$40,000STREET
BOSTON CHILDREN'S HOSPITAL
C/O BANK OF AMERICA 1295 BOYLSTONBOSTONMA022155724PCCHILD HEALTH RESEARCH AWARD - MACHINE-LEARNING PREDICTION MODEL FOR PERSONALIZED URINARY TRACT INFECTION CARE IN CHILDREN$40,000STREET 4TH FL
BROWN UNIVERSITY
CASHIER OFFICE BOX 1997 69 BROWNPROVIDENCERI02912PCCHILD HEALTH RESEARCH AWARD - DEVELOPMENT OF A HIGH EFFICACY NON-CAPSID NOROVIRUS VACCINE$40,000STREET 2ND FLOOR
HARVARD MEDICAL SCHOOL
C/O BANK OF AMERICA 100 FEDERALBOSTONMA02110PCCHILD HEALTH RESEARCH AWARD - DECIPHERING MECHANISMS LINKING CHILDHOOD VIRAL INFECTION AND ASTHMA DEVELOPMENT$40,000STREET
WORCESTER POLYTECHNIC INSTITUTE
C/O TD BANK 370 MAIN STWORCESTERMA01608PCCHILD HEALTH RESEARCH AWARD - ROLE OF HETEROTRIMERIC G PROTEINS IN CILIA ASSEMBLY AND PATHOGENESIS OF NEURODEVELOPMENTAL DISORDERS$40,000
YALE UNIVERSITY
C/O BANK OF AMERICA MERRILL LYNCHNEW YORKNY10001PCCHILD HEALTH RESEARCH AWARD - DIAGNOSIS OF PEDIATRIC MALIGNANCIES USING DEVELOPMENTAL MAPPING AND MACHINE LEARNING$40,000100 WEST 33RD STREET
FieldValueIRS element (for citing)
Total Grant Or Contri Apprv Fut$905,250TotalGrantOrContriApprvFutAmt

Analysis Income Producing Acty AnalysisIncomeProducingActyGrp

Dividends And Interest From Sec Dtl DividendsAndInterestFromSecDtl

FieldValueIRS element (for citing)
Exclusion14ExclusionCd
Exclusion$1,335,080ExclusionAmt

Gain Sales Ast Oth Than Invntry GainSalesAstOthThanInvntryGrp

FieldValueIRS element (for citing)
Exclusion18ExclusionCd
Exclusion$612,940ExclusionAmt

Other Revenue Described OtherRevenueDescribedGrp (2 entries)

DescDescRelated Or Exempt Function IncmRelatedOrExemptFunctionIncmAmt
RETURNED GRANT FUNDS$31,917
OTHER INVESTMENT INCOME$5,343

Subtotals Incm Producing Acty SubtotalsIncmProducingActyGrp

FieldValueIRS element (for citing)
Unrelated Business Taxbl Incm$0UnrelatedBusinessTaxblIncmAmt
Exclusion$1,948,020ExclusionAmt
Related Or Exempt Function Incm$37,260RelatedOrExemptFunctionIncmAmt
FieldValueIRS element (for citing)
Total Income Producing Acty$1,985,280TotalIncomeProducingActyAmt

Rln Of Acty To Accom Of Exmpt Prps RlnOfActyToAccomOfExmptPrpsGrp

Rln Of Acty To Accom Of Exmpt Prps RlnOfActyToAccomOfExmptPrpsGrp (2 entries)

Line NumberLineNumberTxtRelationship StatementRelationshipStatementTxt
11AEXCESS FUNDS RETURNED FROM GRANTS PREVIOUSLY PAID OUT.
11BSETTLEMENT PROCEEDS ON INVESTMENTS

Trnsfr Trans Rln Nonchrtbl EO TrnsfrTransRlnNonchrtblEOGrp

FieldValueIRS element (for citing)
Trnsfr Of Cash To Nonchrtbl EO0TrnsfrOfCashToNonchrtblEOInd
Trnsfr Other Asset Nonchrtbl EO0TrnsfrOtherAssetNonchrtblEOInd
Sales Or Exchanges Of Assets0SalesOrExchangesOfAssetsInd
Purchase Of Assets Nonchrtbl EO0PurchaseOfAssetsNonchrtblEOInd
Rental Of Facilities Oth Assets0RentalOfFacilitiesOthAssetsInd
Reimbursement Arrangements0ReimbursementArrangementsInd
Loans Or Loan Guarantees0LoansOrLoanGuaranteesInd
Performance Of Services Etc0PerformanceOfServicesEtcInd
Sharing Of Facilities Etc0SharingOfFacilitiesEtcInd
Relationships Nonchrtbl EO0RelationshipsNonchrtblEOInd

Schedule B IRS990ScheduleB

FieldValueIRS element (for citing)
Organization501c3 Exempt PFYes (X)Organization501c3ExemptPFInd
General RuleYes (X)GeneralRuleInd

Contributor Information ContributorInformationGrp

FieldValueIRS element (for citing)
Contributor1ContributorNum
Contributor PersonESTATE OF JUDITH HOODContributorPersonNm

Contributor US Address ContributorUSAddress

FieldValueIRS element (for citing)
Address Line1BANK OF AMERICA 1025 MAIN STREET MAAddressLine1Txt
CityWALTHAMCityNm
State AbbreviationMEStateAbbreviationCd
ZIP02451ZIPCd
FieldValueIRS element (for citing)
Total Contributions$1,029,761TotalContributionsAmt
Person ContributionYes (X)PersonContributionInd

Accounting Fees Schedule AccountingFeesSchedule

Accounting Fees Detail AccountingFeesDetail

FieldValueIRS element (for citing)
CategoryACCOUNTING & TAX PREPARATION FEESCategoryTxt
Amt$26,003Amt
Net Investment Income$0NetInvestmentIncomeAmt
Disbursements Charitable Prps$26,003DisbursementsCharitablePrpsAmt

All Oth Prog Rltd Investments Sch AllOthProgRltdInvestmentsSch

All Other Program Related Invst AllOtherProgramRelatedInvstGrp (3 entries)

DescDescAmtAmt
SMOLTAP - PROVIDENCE, RI SERIES SEED PREFERRED STOCK INVESTMENT$99,997
NOVONATE - SOUTH SAN FRANCISCO, CA SAFE - SIMPLE AGREEMENT FOR FUTURE EQUITY$150,000
BIOROSA TECHNOLOGIES - BELMONT, MA UNSECURED CONVERTIBLE PROMISSORY NOTE$100,000

Expenditure Responsibility Stmt ExpenditureResponsibilityStmt

Expenditure Responsibility ExpenditureResponsibilityGrp (19 entries)

Address Line1USAddress/AddressLine1TxtCityUSAddress/CityNmState AbbreviationUSAddress/StateAbbreviationCdZIPUSAddress/ZIPCdGrantGrantDtGrantGrantAmtPurpose Of GrantPurposeOfGrantTxtExpended By GranteeExpendedByGranteeAmtAny Diversion By GranteeAnyDiversionByGranteeTxtDates Of Reports By GranteeDatesOfReportsByGranteeTxtVerificationVerificationDtResults Of VerificationResultsOfVerificationTxtAddress Line2USAddress/AddressLine2TxtAddress Line1ForeignAddress/AddressLine1TxtCityForeignAddress/CityNmProvince Or StateForeignAddress/ProvinceOrStateNmCountryForeignAddress/CountryCdForeign PostalForeignAddress/ForeignPostalCd
NONINVASIX INC
1700 THE STRAND SUITE 1200GALVESTONTX775552017-07-27$7,000TO FUND NONINVASIX'S PARTICIPATION IN THE PHILIPS' MATERNAL AND INFANT HEALTHWORKS START-UP PROGRAM.$7,000NONE, SEE BELOWPRI REPORTS - 4/28/2023, 5/25/20232017-12-15THE TRUSTEES MEET WITH NONINVASIX, INC. MANAGEMENT ON A REGULAR BAS1S, ATTEND BOARD MEETINGS AS AN OBSERVER AND REVIEW THE PRI REPORTS AND FINANCIALS. TO THE TRUSTEES KNOWLEDGE, THE GRANTEE HAS NOT DIVERTED ANY OF THE FUNDS FROM THE PURPOSE OF THE GRANT. NO ADDITIONAL FOLLOW UP DEEMED NECESSARY
BREEGI SCIENTIFIC INC
120 BEDFORD ROADWOBURNMA018012017-06-26$250,000THE FUNDS WILL BE USED TO CONDUCT A THOROUGH CLINICAL ASSESSMENT OF BSI'S NOVEL NEONATAL INTENSIVE CARE INCUBATOR "(NICI)" IN HONDURAS AND ZAMBIA AND TO AID THE COMMERCIALIZATION EFFORTS OF THIS LIFE-SAVING MEDICAL DEVICE, THEREBY LESSENING THE BURDEN OF THE GOVERNMENT AND RELIEF OF THE POOR, DISTRESSED AND UNDERPRIVILEGED.$250,000NONE, SEE BELOWPRI REPORTS - 6/13/2022, 9/13/2022, 1/5/2023, 8/24/20232021-08-02THE TRUSTEES MEET WITH BREEGI SCIENTIFIC, INC. MANAGEMENT ON A REGULAR BASIS AND REVIEW THE PRI REPORTS AND FINANCIALS. TO THE TRUSTEES KNOWLEDGE, THE GRANTEE HAS NOT DIVERTED ANY OF THE FUNDS FROM THE PURPOSE OF THE GRANT. NO ADDITIONAL FOLLOW UP DEEMED NECESSARY
NONINVASIX INC
1700 THE STRAND SUITE 1200GALVESTONTX775552015-12-30$150,000TO SUPPORT THE USE AND DEVELOPMENT OF THE COMPANY'S PEDIATRIC BRAIN OXYGENATION MONITORING SYSTEM, WHICH HAS THE POTENTIAL TO MORE ACCURATELY ASSESS THE RISK OF BRAIN HYPOXIA IN FETUSES AND NEONATES, THEREBY SUPPORTING THE ADVANCEMENT OF SCIENCE AND LESSENING THE BURDEN OF THE GOVERNMENT.$150,000NONE, SEE BELOWPRI REPORTS -4/28/2023, 5/25/20232017-12-15THE TRUSTEES MEET WITH NONINVASIX, INC. MANAGEMENT ON A REGULAR BAS1S, ATTEND BOARD MEETINGS AS AN OBSERVER AND REVIEW THE PRI REPORTS AND FINANCIALS. TO THE TRUSTEES KNOWLEDGE, THE GRANTEE HAS NOT DIVERTED ANY OF THE FUNDS FROM THE PURPOSE OF THE GRANT. NO ADDITIONAL FOLLOW UP DEEMED NECESSARY
ALDATU BIOSCIENCES INC
C/O ARSENAL LAB SPACE 201 DEXTERWATERTOWNMA024722016-02-23$100,000TO SUPPORT THE USE AND DEVELOPMENT OF A SIMPLE, RAPID, THERMOSTABLE KIT THAT IDENTIFIES CLINICALLY ACTIONABLE HIV MUTATIONS FOUND IN PATIENTS FAILING A FIRST-LINE DRUG REGIMEN, THEREBY SUPPORTING THE ADVANCEMENT OF SCIENCE AND RELIEF OF THE POOR, DISTRESSED AND UNDERPRIVILEGED.$100,000NONE, SEE BELOWPRI REPORTS - 6/14/2022, 12/1/2022, 5/26/2023, 6/12/20232017-12-15THE TRUSTEES MEET WITH ALDATU BIOSCIENCES, INC. MANAGEMENT ON A REGULAR BASIS AND REVIEW THE PRI REPORTS AND FINANCIALS. TO THE TRUSTEES KNOWLEDGE, THE GRANTEE HAS NOT DIVERTED ANY OF THE FUNDS FROM THE PURPOSE OF THE GRANT. NO ADDITIONAL FOLLOW UP DEEMED NECESSARY.AVE
NONINVASIXINC
1700 THE STRAND SUITE 1200GALVESTONTX775552016-07-27$150,000TO SUPPORT THE USE AND DEVELOPMENT OF THE COMPANY'S PEDIATRIC BRAIN OXYGENATION MONITORING SYSTEM, WHICH HAS THE POTENTIAL TO MORE ACCURATELY ASSESS THE RISK OF BRAIN HYPOXIA IN FETUSES AND NEONATES, THEREBY SUPPORTING THE ADVANCEMENT OF SCIENCE AND LESSENING THE BURDEN OF THE GOVERNMENT.$150,000NONE, SEE BELOWPRI REPORT - 4/28/2023, 5/25/20232017-12-15THE TRUSTEES MEET WITH NONINVASIX, INC. MANAGEMENT ON A REGULAR BAS1S, ATTEND BOARD MEETINGS AS AN OBSERVER AND REVIEW THE PRI REPORTS AND FINANCIALS. TO THE TRUSTEES KNOWLEDGE, THE GRANTEE HAS NOT DIVERTED ANY OF THE FUNDS FROM THE PURPOSE OF THE GRANT. NO ADDITIONAL FOLLOW UP DEEMED NECESSARY
THINKMD INC
166 MAIN STREETBURLINGTONVT054012018-05-17$150,000FOR DEVELOPING INTEGRATED CLINICAL ASSESSMENT AND DATA ANALYTICS PLATFORMS AND OTHER DERIVATIVE PRODUCTS THAT TRANSFORM POINT-OF-CARE MEDICINE BY PUTTING VALIDATED CLINICAL ASSESSMENT CAPABILITY AND INCREASED HEALTHCARE KNOWLEDGE INTO THE HANDS OF CLINICALLY UNTRAINED HEALTHCARE PROFESSIONALS AND FAMILIES THEREBY LESSENING THE BURDEN OF THE GOVERNMENT, AND RELIEF OF THE POOR, DISTRESSED AND UNDERPRIVILEGED.$150,000NONE, SEE BELOWPRI REPORTS - 5/4/22, 7/31/22, 11/15/22, 2/20/23, 5/16/23, 6/2/23, 7/5/232019-02-11THE TRUSTEES MEET WITH THINKMD, INC. MANAGEMENT ON A REGULAR BAS1S, ATTEND BOARD MEETINGS AS AN OBSERVER AND REVIEW THE PRI REPORTS AND FINANCIALS. TO THE TRUSTEES KNOWLEDGE, THE GRANTEE HAS NOT DIVERTED ANY OF THE FUNDS FROM THE PURPOSE OF THE GRANT. NO ADDITIONAL FOLLOW UP DEEMED NECESSARY.
PRAPELA LLC
2 MAIN STREETBIDDEFORDME040052018-07-02$250,000TO SUPPORT THE DEVELOPMENT OF THE COMPANY'S SLEEP TECHNOLOGY PRODUCTS FOR IMPROVING THE HEALTH OF INFANTS WHO COULD BENEFIT FROM WITHDRAWAL TREATMENT AND POST-WITHDRAWAL SUPPORT OF NEONATAL ABSTINENCE SYNDROME ("NAS") A CONDITION CAUSED BY THE PRENATAL USE OF OPIOIDS OR OTHER DRUGS BY PREGNANT WOMEN, THEREBY SUPPORTING THE ADVANCEMENT OF SCIENCE, LESSENING THE BURDEN OF THE GOVERNMENT, AND RELIEF OF THE POOR, DISTRESSED AND UNDERPRIVILEGED.$250,000NONE, SEE BELOWPRI REPORTS - 5/6/2022, 3/1/2023, 6/22/2023, 7/10/20232020-09-10THE TRUSTEES MEET WITH PRAPELA, LLC MANAGEMENT ON A REGULAR BAS1S, ATTEND BOARD MEETINGS AS AN OBSERVER AND REVIEW THE PRI REPORTS AND FINANCIALS. TO THE TRUSTEES KNOWLEDGE, THE GRANTEE HAS NOT DIVERTED ANY OF THE FUNDS FROM THE PURPOSE OF THE GRANT. NO ADDITIONAL FOLLOW UP DEEMED NECESSARY.
STINGRAY THERAPEUTICS
2450 HOLCOMBE BLVD SUITE XHOUSTONTX770212019-04-08$250,000FUNDS WILL BE USED FOR PRECLINICAL WORK FOCUSED ON PEDIATRIC BRAIN CANCERS, INCLUDING WORK TO DEVELOP PRECLINICAL MODELS AND TO TEST COMPOUNDS AGAINST MEDULLOBLASTOMA, AN ULTRA-RARE PEDIATRIC BRAIN CANCER, THEREBY SUPPORTING THE ADVANCEMENT OF SCIENCE.$250,000NONE, SEE BELOWPRI REPORTS - 2/17/22, 5/11/22, 9/30/2022, 3/2/2023, 5/25/2023, 6/29/20232021-05-18THE TRUSTEES MEET WITH STINGRAY THERAPEUTICS MANAGEMENT ON A REGULAR BAS1S, ATTEND BOARD MEETINGS AS AN OBSERVER AND REVIEW THE PRI REPORTS AND FINANCIALS. TO THE TRUSTEES KNOWLEDGE, THE GRANTEE HAS NOT DIVERTED ANY OF THE FUNDS FROM THE PURPOSE OF THE GRANT. NO ADDITIONAL FOLLOW UP DEEMED NECESSARY.
149 MEDICAL INC
1173 MAIN STREETBOLTONMA017402020-04-17$150,000TO SUPPORT THE PRE-COMMERCIALIZATION DEVELOPMENT OF A MONITOR THAT MEASURES REAL-TIME BRAIN HEMODYNAMICS AND METABOLISM IN PRETERM NEWBORNS, IN AN ATTEMPT TO CHANGE THE STANDARD OF CARE BY IMPROVING LIVES, REDUCING MEDICAL ERRORS, AND REDUCING OVERALL HEALTHCARE COSTS, THEREBY SUPPORTING THE ADVANCEMENT OF SCIENCE AND LESSENING THE BURDEN OF THE GOVERNMENT.$150,000NONE, SEE BELOWPRI REPORT - 2/17/2022, 4/6/2022, 6/10/2022,8/25/2022, 9/22/2022, 8/16/20232022-06-10THE TRUSTEES MEET WITH 149 MEDICAL, INC. ON A REGULAR BAS1S, ATTEND BOARD MEETINGS AS AN OBSERVER AND REVIEW THE PRI REPORTS AND FINANCIALS. TO THE TRUSTEES KNOWLEDGE, THE GRANTEE HAS NOT DIVERTED ANY OF THE FUNDS FROM THE PURPOSE OF THE GRANT. NO ADDITIONAL FOLLOW UP DEEMED NECESSARY
ANIDA PHARMA INC
155 BROOKLINE STREET SUITE 005CAMBRIDGEMA021392020-12-21$250,000TO SUPPORT THE PRECLINICAL DEVELOPMENT OF A PREVENTATIVE TREATMENT FOR RETINOPATHY OF PREMATURITY, THEREBY SUPPORTING THE ADVANCEMENT OF SCIENCE AND RELIEF OF THE POOR, DISTRESSED AND UNDERPRIVILEGED.$250,000NONE, SEE BELOWPRI REPORT 6/11/2022, 8/29/2022, 7/21/2023, 8/23/20232023-07-21THE TRUSTEES MEET WITH ANIDA PHARMA, INC. MANAGEMENT ON A REGULAR BAS1S, ATTEND BOARD MEETINGS AS AN OBSERVER AND REVIEW THE PRI REPORTS AND FINANCIALS. TO THE TRUSTEES KNOWLEDGE, THE GRANTEE HAS NOT DIVERTED ANY OF THE FUNDS FROM THE PURPOSE OF THE GRANT. NO ADDITIONAL FOLLOW UP DEEMED NECESSARY
BIOROSA TECHNOLOGIES INC
63 BAKER STREETBELMONTMA024782020-07-15$150,000TO SUPPORT THE DEVELOPMENT OF A BLOOD-BASED STANDARD-OF-CARE DIAGNOSTIC FOR AUTISM SPECTRUM DISORDERS ("ASD") THAT IS INTENDED TO LEAD TO EARLIER DETECTION OF ASD THAN IS CURRENTLY AVAILABLE, THEREBY SUPPORTING THE ADVANCEMENT OF SCIENCE AND LESSENING THE BURDEN OF THE GOVERNMENT.$150,000NONE, SEE BELOWPRI REPORTS - 1/27/2022, 5/16/2022, 6/22/2022, 12/11/2022, 8/14/20232021-07-16THE TRUSTEES MEET WITH BIOROSA TECHNOLOGIES, INC. MANAGEMENT ON A REGULAR BAS1S, ATTEND BOARD MEETINGS AS AN OBSERVER AND REVIEW THE PRI REPORTS AND FINANCIALS. TO THE TRUSTEES KNOWLEDGE, THE GRANTEE HAS NOT DIVERTED ANY OF THE FUNDS FROM THE PURPOSE OF THE GRANT. NO ADDITIONAL FOLLOW UP DEEMED NECESSARY
MESENTECH INC
2020-11-02$250,000TO SUPPORT THE ADVANCEMENT OF SCIENCE AND PROMOTION OF HEALTH THROUGH THE PRECLINICAL RESEARCH OF ANABOLIC BONE THERAPEUTICS THAT CAN INCREASE BONE MASS TO STRENGTHEN THE SKELETON AND THE DEVELOPMENT OF A DRUG DELIVERY SYSTEM TO BE INITIALLY APPLIED TO TWO PEDIATRIC RARE DISEASES: OSTEOGENESIS IMPERFECTA AND DUCHENNE MUSCULAR DYSTROPHY.$250,000NONE, SEE BELOWPRI REPORT - 2/10/2022, 8/26/2022, 12/19/2022, 7/3/20232022-08-26THE TRUSTEES MEET WITH MESENTECH, INC. MANAGEMENT ON A REGULAR BAS1S, ATTEND BOARD MEETINGS AS AN OBSERVER AND REVIEW THE PRI REPORTS AND FINANCIALS. TO THE TRUSTEES KNOWLEDGE, THE GRANTEE HAS NOT DIVERTED ANY OF THE FUNDS FROM THE PURPOSE OF THE GRANT. NO ADDITIONAL FOLLOW UP DEEMED NECESSARY2222 HEALTH SCIENCES RDVANCOUVERBRITISH COLUMBIACAV6T2B9
ARGUS COGNITIVE INC
DARTMOUTH REGIONAL TECHNICAL CENTERLEBANONNH037662021-05-10$250,000TO SUPPORT THE DEVELOPMENT AND CLINICAL TESTING OF THE CORPORATION'S CLINICAL DECISION SUPPORT SOFTWARE FOR USE IN PEDIATRIC INDICATIONS, INCLUDING AUTISM AND PEDIATRIC CARDIOLOGY, THEREBY SUPPORTING RELIEF OF THE POOR, DISTRESSED AND UNDERPRIVILEGED AND LESSENING THE BURDEN OF THE GOVERNMENT.$250,000NONE, SEE BELOWPRI REPORT - 6/24/2022, 9/29/2022, 11/30/2022, 8/23/20232023-08-23THE TRUSTEES MEET WITH ARGUS COGNITIVE, INC. MANAGEMENT ON A REGULAR BAS1S, ATTEND BOARD MEETINGS AS AN OBSERVER AND REVIEW THE PRI REPORTS AND FINANCIALS. TO THE TRUSTEES KNOWLEDGE, THE GRANTEE HAS NOT DIVERTED ANY OF THE FUNDS FROM THE PURPOSE OF THE GRANT. NO ADDITIONAL FOLLOW UP DEEMED NECESSARY16 CAVENDISH
NICOLETTE INC
100 W BROADWAY SUITE 3000LONG BEACHCA908022021-12-23$200,000TO DEVELOP AND TEST A TABLET-BASED APPLICATION THAT TRANSLATES DATA PULLED FROM A BABY'S ELECTRONIC MEDICAL RECORD INTO EASILY UNDERSTOOD, SIMPLE SENTENCES COMPLEMENTED BY VISUAL AIDS, SUCH AS GRAPHS AND CHARTS, FOR THE BENEFIT OF THE PUBLIC, INCLUDING PARENTS, IN AN ATTEMPT TO CHANGE THE STANDARD OF CARE BY IMPROVING LIVES, REDUCING MEDICAL ERRORS, AND REDUCING OVERALL HEALTHCARE COSTS.$194,650NONE, SEE BELOWPRI REPORT - 1/3/2022, 5/2/2022, 7/26/20232023-07-26THE TRUSTEES MEET WITH NICOLETTE, INC. MANAGEMENT ON A REGULAR BAS1S, ATTEND BOARD MEETINGS AS AN OBSERVER AND REVIEW THE PRI REPORTS AND FINANCIALS. TO THE TRUSTEES KNOWLEDGE, THE GRANTEE HAS NOT DIVERTED ANY OF THE FUNDS FROM THE PURPOSE OF THE GRANT. NO ADDITIONAL FOLLOW UP DEEMED NECESSARY
SMOLTAP INC
150 CHESTNUT STREET SUITE CPROVIDENCERI029032022-07-25$99,997TO SUPPORT THE PERFORMANCE OF SCIENTIFIC RESEARCH TO DEVELOP A NOVEL DEVICE WHICH HOLDS AN INFANT STABLE DURING THE LUMBER PUNCTURE PROCEDURE WHEN ADMINISTERING A SPINAL TAP TO DIAGNOSE MENINGITIS IN IN FEBRILE INFANTS UP TO FOUR WEEKS OLD.$99,997NONE, SEE BELOWPRI REPORT - 8/30/2022, 2/15/2023, 5/30/20232023-05-30THE TRUSTEES MEET WITH SMOLTAP, INC. MANAGEMENT ON A REGULAR BASIS AND REVIEW THE PRI REPORTS AND FINANCIALS. TO THE TRUSTEES KNOWLEDGE, THE GRANTEE HAS NOT DIVERTED ANY OF THE FUNDS FROM THE PURPOSE OF THE GRANT. NO ADDITIONAL FOLLOW UP DEEMED NECESSARY
NOVONATE INC
395 OYSTER POINT BLVD SUITE 501SOUTH SAN FRANCISCOCA940802022-08-03$150,000TO SUPPORT THE PERFORMANCE OF SCIENTIFIC RESEARCH TO BENEFIT THE PUBLIC BY DEVELOPING MEDICAL DEVICES FOR PATIENTS IN THE NEONATAL INTENSIVE CARE UNIT.$123,600NONE, SEE BELOWPRI REPORT - 8/9/2022, 8/12/2022, 7/25/2023, 7/27/20232023-07-27THE TRUSTEES MEET WITH NOVONATE, INC. MANAGEMENT ON A REGULAR BASIS AND REVIEW THE PRI REPORTS AND FINANCIALS. TO THE TRUSTEES KNOWLEDGE, THE GRANTEE HAS NOT DIVERTED ANY OF THE FUNDS FROM THE PURPOSE OF THE GRANT. NO ADDITIONAL FOLLOW UP DEEMED NECESSARY
DECK THERAPEUTICS INC
8 HARVARD LANEHASTINGS ON HUDSONNY107062022-10-12$200,000TO SUPPORT THE DEVELOPMENT OF SEMI-SYNTHETIC OMEGA-3 COMPOUNDS THAT BLOCK MULTIPLE CELL-DEATH PATHWAYS INDUCED BY HYPOXIC-ISCHEMIC INJURY IN NEONATES.$51,666NONE, SEE BELOWPRI REPORTS - 10/2022, 3/29/20232023-03-29THE TRUSTEES MEET WITH DECK THERAPEUTICS, INC. MANAGEMENT ON A REGULAR BASIS AND REVIEW THE PRI REPORTS AND FINANCIALS. TO THE TRUSTEES KNOWLEDGE, THE GRANTEE HAS NOT DIVERTED ANY OF THE FUNDS FROM THE PURPOSE OF THE GRANT. NO ADDITIONAL FOLLOW UP DEEMED NECESSARY
INKSPACE IMAGING INC
5635 W LAS POSITAS BLVD STE 403/404PLEASANTONCA945882022-10-20$250,000TO SUPPORT THE DEVELOPMENT OF FLEXIBLE, LIGHTWEIGHT, LOW COST MRI COILS DESIGNED SPECIFICALLY FOR PEDIATRIC PATIENTS, WHILE ALSO IMPROVING IMAGE RESOLUTION AND REDUCING MRI FAILURE RATES.$64,848NONE, SEE BELOWPRI REPORT - 12/23/2022, 6/5/20232023-06-05THE TRUSTEES MEET WITH INKSPACE IMAGING, INC. MANAGEMENT ON A REGULAR BASIS AND REVIEW THE PRI REPORTS AND FINANCIALS. TO THE TRUSTEES KNOWLEDGE, THE GRANTEE HAS NOT DIVERTED ANY OF THE FUNDS FROM THE PURPOSE OF THE GRANT. NO ADDITIONAL FOLLOW UP DEEMED NECESSARY
BIOROSA TECHNOLOGIES INC
63 BAKER STREETBELMONTMA024782022-11-15$100,000TO SUPPORT THE DEVELOPMENT OF A BLOOD-BASED STANDARD-OF-CARE DIAGNOSTIC FOR AUTISM SPECTRUM DISORDERS ("ASD") THAT IS INTENDED TO LEAD TO EARLIER DETECTION OF ASD THAN IS CURRENTLY AVAILABLE, THEREBY SUPPORTING THE ADVANCEMENT OF SCIENCE AND LESSENING THE BURDEN OF THE GOVERNMENT.$100,000NONE, SEE BELOWPRI REPORTS - 1/27/2022, 5/16/2022, 6/22/2022, 12/11/2022, 8/14/20232023-08-14THE TRUSTEES MEET WITH BIOROSA TECHNOLOGIES, INC. MANAGEMENT ON A REGULAR BAS1S, ATTEND BOARD MEETINGS AS AN OBSERVER AND REVIEW THE PRI REPORTS AND FINANCIALS. TO THE TRUSTEES KNOWLEDGE, THE GRANTEE HAS NOT DIVERTED ANY OF THE FUNDS FROM THE PURPOSE OF THE GRANT. NO ADDITIONAL FOLLOW UP DEEMED NECESSARY

Investments Corp Bonds Schedule InvestmentsCorpBondsSchedule

Investments Corporate Bonds InvestmentsCorporateBondsGrp

FieldValueIRS element (for citing)
BondFIXED INCOMEBondNm
EOY Book Value$13,292,160EOYBookValueAmt
EOYFMV$13,292,160EOYFMVAmt

Investments Corp Stock Schedule InvestmentsCorpStockSchedule

Investments Corporate Stock InvestmentsCorporateStockGrp (2 entries)

StockStockNmEOY Book ValueEOYBookValueAmtEOYFMVEOYFMVAmt
DOMESTIC EQUITIES$25,060,411$25,060,411
FOREIGN SECURITIES$9,777,340$9,777,340

Investments Other Schedule2 InvestmentsOtherSchedule2

Investments Other InvestmentsOtherGrp (2 entries)

Category Or ItemCategoryOrItemTxtListed At Cost Or FMVListedAtCostOrFMVCdBook ValueBookValueAmtEOYFMVEOYFMVAmt
REAL ESTATEFMV$2,586,626$2,586,626
ALTERNATIVE INVESTMENTSFMV$12,208,432$12,208,432

Legal Fees Schedule LegalFeesSchedule

Legal Fees LegalFeesGrp

FieldValueIRS element (for citing)
CategoryLEGAL EXPENSESCategoryTxt
Legal Fees$30,210LegalFeesAmt
Net Investment Income$0NetInvestmentIncomeAmt
Disbursements Charitable Prps$30,210DisbursementsCharitablePrpsAmt

Other Assets Schedule OtherAssetsSchedule

Other Assets Schedule OtherAssetsScheduleGrp

FieldValueIRS element (for citing)
DescPROGRAM RELATED INVESTMENTSDesc
BOY Book Value$2,569,964BOYBookValueAmt
EOY Book Value$3,369,961EOYBookValueAmt
EOYFMV$3,369,961EOYFMVAmt

Other Decreases Schedule OtherDecreasesSchedule

Other Decreases Detail OtherDecreasesDetail (2 entries)

DescDescAmtAmt
UNREALIZED LOSSES$11,863,391
LOSS ON ALTERNATIVE INVESTMENTS$109,265

Other Expenses Schedule OtherExpensesSchedule

Other Expenses Schedule OtherExpensesScheduleGrp (9 entries)

DescDescRevenue And Expenses Per BooksRevenueAndExpensesPerBooksAmtNet Investment IncomeNetInvestmentIncomeAmtDisbursements Charitable PrpsDisbursementsCharitablePrpsAmt
FILING FEES$539$0$539
MISCELLANEOUS EXPENSES$3,968$0$3,968
HRIA ADMINISTRATIVE COSTS$199,378$0$199,378
PROGRAM RELATED INVESTMENT ADMINISTRATIVE COSTS$18,132$0$18,132
MARKETING$14,214$0$14,214
HONORARIA$13,025$0$13,025
SCIENTIFIC ADVISORS$35,190$0$35,190
EVENT EXPENSE$112,808$0$112,808
OFFICERS' INSURANCE$947$0$947

Other Income Schedule2 OtherIncomeSchedule2

Other Income Detail OtherIncomeDetail (2 entries)

DescDescRevenue And Expenses Per BooksRevenueAndExpensesPerBooksAmtAdjusted Net IncomeAdjustedNetIncomeAmt
RETURNED GRANT FUNDS$31,917$31,917
OTHER INVESTMENT INCOME$5,343$5,343

Other Professional Fees Schedule OtherProfessionalFeesSchedule

Other Professional Fees Detail OtherProfessionalFeesDetail (2 entries)

CategoryCategoryTxtAmtAmtNet Investment IncomeNetInvestmentIncomeAmtDisbursements Charitable PrpsDisbursementsCharitablePrpsAmt
INVESTMENT FEES - US TRUST$28,585$14,292$14,293
INVESTMENT CONSULTING$75,000$75,000$0

Taxes Schedule TaxesSchedule

Taxes Detail TaxesDetail (3 entries)

CategoryCategoryTxtAmtAmtNet Investment IncomeNetInvestmentIncomeAmtDisbursements Charitable PrpsDisbursementsCharitablePrpsAmt
FEDERAL EXCISE TAXES FOR 2022$57,779$0$0
MA FORM PC FILING FEE FOR 2021$500$0$500
FOREIGN TAXES$25,400$25,400$0

Comments

Anonymous: no account or email. Up to 2,000 characters, at most one link. Comments are checked automatically; some wait for review.